JP2004504379A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504379A5
JP2004504379A5 JP2002514092A JP2002514092A JP2004504379A5 JP 2004504379 A5 JP2004504379 A5 JP 2004504379A5 JP 2002514092 A JP2002514092 A JP 2002514092A JP 2002514092 A JP2002514092 A JP 2002514092A JP 2004504379 A5 JP2004504379 A5 JP 2004504379A5
Authority
JP
Japan
Prior art keywords
pyrrolidine
carboxylic acid
mercapto
alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002514092A
Other languages
English (en)
Japanese (ja)
Other versions
JP3983663B2 (ja
JP2004504379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/007951 external-priority patent/WO2002008185A1/en
Publication of JP2004504379A publication Critical patent/JP2004504379A/ja
Publication of JP2004504379A5 publication Critical patent/JP2004504379A5/ja
Application granted granted Critical
Publication of JP3983663B2 publication Critical patent/JP3983663B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002514092A 2000-07-19 2001-07-10 メタロプロテアーゼインヒビターとしてのピロリジン誘導体 Expired - Lifetime JP3983663B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00114949 2000-07-19
PCT/EP2001/007951 WO2002008185A1 (en) 2000-07-19 2001-07-10 Pyrrolidine derivatives as metalloprotease inhibitors

Publications (3)

Publication Number Publication Date
JP2004504379A JP2004504379A (ja) 2004-02-12
JP2004504379A5 true JP2004504379A5 (enExample) 2005-02-24
JP3983663B2 JP3983663B2 (ja) 2007-09-26

Family

ID=8169226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002514092A Expired - Lifetime JP3983663B2 (ja) 2000-07-19 2001-07-10 メタロプロテアーゼインヒビターとしてのピロリジン誘導体

Country Status (15)

Country Link
US (3) US20020040146A1 (enExample)
EP (1) EP1303486A1 (enExample)
JP (1) JP3983663B2 (enExample)
KR (1) KR100613196B1 (enExample)
CN (1) CN100406439C (enExample)
AR (1) AR037990A1 (enExample)
AU (2) AU7847901A (enExample)
BR (1) BR0112655A (enExample)
CA (1) CA2415740A1 (enExample)
MX (1) MXPA03000368A (enExample)
PA (1) PA8522301A1 (enExample)
PE (1) PE20020333A1 (enExample)
UY (1) UY26846A1 (enExample)
WO (1) WO2002008185A1 (enExample)
ZA (1) ZA200300170B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112655A (pt) * 2000-07-19 2003-06-24 Hoffmann La Roche Derivados de pirrolidino como inibidores de metaloproteases
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
MXPA05003715A (es) 2002-10-07 2005-09-30 Univ California Modulacion de ansiedad a traves de bloqueo de hidrolisis de anandamida.
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
EP2234608A2 (en) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US8404866B2 (en) * 2008-09-03 2013-03-26 Florida State University Research Foundation Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors
TWI759267B (zh) 2015-07-02 2022-04-01 美商地平線罕見醫學製藥有限責任公司 Ado抗性半胱胺類似物及其用途
EP3740466B1 (en) * 2018-01-17 2024-03-06 Migal Galilee Research Institute Ltd. New methionine metabolic pathway inhibitors
CN111825582B (zh) * 2020-08-12 2022-04-08 江西理工大学 一种以芳基磺酰氯为硫源合成β-硫代羰基化合物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
GB9301276D0 (en) * 1993-01-22 1993-03-17 Fujisawa Pharmaceutical Co Bicyclic compounds and their preparation
CA2184101C (en) * 1994-02-25 2005-11-22 Susumu Nakagawa Carbapenem derivatives
HUP9902316A3 (en) * 1996-02-13 2001-12-28 Abbott Lab 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing them
BR9713465A (pt) * 1996-08-28 2000-03-28 Procter & Gamble Inibidores metalotprotease de amina cìclica sibstituìda
BR9712792A (pt) * 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
AU2001270627A1 (en) * 2000-07-19 2002-01-30 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
BR0112655A (pt) * 2000-07-19 2003-06-24 Hoffmann La Roche Derivados de pirrolidino como inibidores de metaloproteases

Similar Documents

Publication Publication Date Title
KR101004224B1 (ko) 인 함유 화합물 및 이의 용도
EP2182950B1 (en) Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
TWI623528B (zh) 金屬酶抑制劑化合物、抑制金屬酶活性之方法、組合物、治療或預防植物疾病或病症之方法及其用途
CN101370786B (zh) 取代的咪唑以及其作为杀虫剂的用途
EP3661560B1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
CN109863140A (zh) 3-氧代-2,6-二苯基-2,3-二氢哒嗪-4-甲酰胺
JP2012519179A5 (enExample)
JP2004504297A5 (enExample)
JP2004504379A5 (enExample)
RU2005135337A (ru) Производные хиназолина для лечения злокачественного новообразования
RU2011146872A (ru) Производные пролина в качестве ингибиторов катепсина
JP2005523248A (ja) ジペプチジルペプチダーゼivの阻害剤
CN102438990A (zh) 取代的2-乙酰胺基-5-芳基-1,2,4-三唑酮和它的用途
JP2004536066A5 (enExample)
JP2010533131A5 (enExample)
JP2006501306A5 (enExample)
WO2018153970A1 (en) Solid forms of 2-[(3r)-3-methylmorpholin-4-yl]-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridine
US20030203890A1 (en) Method for treating nerve injury caused as a result of surgery
EP3558960B1 (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
CA2304647A1 (en) Method for preventing and treating hearing loss using sensorineurotophic compounds
JP7416757B2 (ja) 置換テトラヒドロシクロペンタ[c]ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法
TW200522951A (en) New methods
RU2007102274A (ru) Пиперазиндионы как антагонисты рецептора окситоцина
CA2784007C (en) Pyrrolidine derivatives
JP2010516817A5 (enExample)